Proliferation of Novel Synthetic Opioids in Postmortem Investigations After Core-Structure Scheduling for Fentanyl-Related Substances
The DOI matches its Crossref record; 103 of the 106 references it cites were found in a registry or an index.
Abstract
New generations of novel synthetic opioids (NSOs) have emerged to fill a void in the illicit drug markets left by the decline in popularity of fentanyl analogs subsequent to core-structure scheduling of fentanyl-related substances in the United States and China. These new opioids include members of the 2-benzyl benzimidazole (eg, isotonitazene, metonitazene, N -pyrrolidino etonitazene, protonitazene, etodesnitazene), benzimidazolone (eg, brorphine), and cinnamylpiperazine (eg, AP-238, 2-methyl AP-237) subclasses. Novel synthetic opioids continue to be detected in opioid-related fatal overdoses, demonstrating the harms associated with exposure to these drugs. Between January 2020 and December 2021, 384 casework blood samples were reported by our laboratory to contain 1 or more of the prior listed 8 NSOs. Isotonitazene (n = 144), metonitazene (n = 122), and brorphine (n = 91) were the 3 most prevalent substances, with positivity for isotonitazene and brorphine peaking just before the announcement of emergency scheduling. These NSOs have been documented as significant drivers of drug mortality, and this case series described here highlights the challenges medical examiners and coroners face in staying current with emerging drugs. Challenges include regional differences, rapid turnover, short lifecycles, variable toxicology testing, and difficulty in assessing individual drug toxicity in polydrug cases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Papsun et al documented this process in detail for the post-fentanyl proliferation of NSOs following core-structure scheduling actions, demonstrating that legislative scheduling of one opioid scaffold reliably predicts the emergence of the next unscheduled class in postmortem casework.3”
From Cychlorphine (N-Propionitrile Chlorphine): An Emerging Benzimidazolone Synthetic Opioid and Its Implications for Overdose Recognition and Management (2026) · cites this paper as [3]
In the citing paper
“Hence, the dynamic nature of the NSO market bolsters the possibility of brorphine analogues to appear in the future, filling the void left by (newly banned) NSOs (Papsun et al., 2022).”
From Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization (2024) · cites this paper as Papsun et al., 2022
In the citing paper
“growing awareness of the dangers related to nitazenes (including the increased implementation of legislative measures (Advisory Council on the Misuse of Drugs, 2023)), may fuel a shift towards newer generations of NSOs, as previously observed for fentanyl analogues (Papsun et al., 2022).”
From Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization (2024) · cites this paper as Papsun et al., 2022
In the citing paper
“However, apart from a relatively straightforward synthesis, other supply- and demand-related factors are known to influence the NSOs (Papsun et al., 2022; Vandeputte et al., 2023b), making it hard to predict how the market will evolve.”
From Elucidating the harm potential of brorphine analogues as new synthetic opioids: Synthesis, in vitro, and in vivo characterization (2024) · cites this paper as Papsun et al., 2022
In the citing paper
“Nitazenes belong to the 2-benzylbenzimidazole synthetic opioid class that was originally synthesized in the mid-20th century during efforts to develop potent analgesic agents [5].”
From Novel 2-Benzylbenzimidazole Opioids: Emerging Drugs of Abuse and Pharmacological Considerations with Nitazene Analogs (2026) · cites this paper as [5]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Drug and Opioid-Involved Overdose Deaths — United States, 2013–2017
Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm675152e1 · Cited by 1,731
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review
Armenian, P., Vo, K. T., Barr-Walker, J., & Lynch, K. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.016 · Cited by 710
A review: Fentanyl and non-pharmaceutical fentanyls
Suzuki, J., & El-Haddad, S. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.033 · Cited by 445
Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July–December 2016
O’Donnell, J. K., Halpin, J., Mattson, C. L., Goldberger, B. A., & Gladden, R. M. (2017) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6643e1 · Cited by 387
Misuse of Novel Synthetic Opioids: A Deadly New Trend
Prekupec, M. P., Mansky, P. A., & Baumann, M. H. (2017) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000324 · Cited by 283
Addressing the Fentanyl Threat to Public Health
Frank, R. G., & Pollack, H. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmp1615145 · Cited by 242
Mohr, A. L. A., Friscia, M., Papsun, D., Kacinko, S. L., Buzby, D., & Logan, B. K. (2016) · Journal of Analytical Toxicology · doi:10.1093/jat/bkw086 · Cited by 199
Self-citationThe Evolving Overdose Epidemic: Synthetic Opioids and Rising Stimulant-Related Harms
Jones, C. M., Bekheet, F., Park, J. N., & Alexander, G. C. (2020) · Epidemiologic Reviews · doi:10.1093/epirev/mxaa011 · Cited by 188
Illicit fentanyls in the opioid street market: desired or imposed?
Mars, S. G., Rosenblum, D., & Ciccarone, D. (2019) · Addiction · doi:10.1111/add.14474 · Cited by 185
An Expanding World of Novel Psychoactive Substances: Opioids
Zawilska, J. B. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00110 · Cited by 175
Research works printed but not linked: 5
- 2012, Benzimidazole and its derivatives–from fungicides to designer drugs. A new occupational and environmental hazards [in Polish], Med Pr, 63, 505
- 2020, Temporary placement of isotonitazene in schedule I, Fed Regist, 85, 36819
- 2021, Etodesnitazene_022321_ToxicologyAnalyticalReport, NPS Discovery at CFSRE
- 2020, Temporary placement of brorphine in schedule I, Fed Regist, 85, 78047
- 2021, Severe toxicity involving N-pyrrolidino etonitazene in the United Kingdom—a case report, Clin Toxicol (Phila), 60, 533
Cited by
New Synthetic Opioids: Clinical Considerations and Dangers
Edinoff, A. N., Martinez Garza, D., Vining, S. P., Vasterling, M. E., Jackson, E. D., Murnane, K. S., Kaye, A. M., Fair, R. N., Torres, Y. J. L., Badr, A. E., et al. (2023) · Pain and Therapy · doi:10.1007/s40122-023-00481-6 · Cited by 61
Non-Fentanyl New Synthetic Opioids—An Update
Zawilska, J. B., Adamowicz, P., Kurpeta, M., & Wojcieszak, J. (2023) · Forensic Science International · doi:10.1016/j.forsciint.2023.111775 · Cited by 55
Glatfelter, G. C., Vandeputte, M. M., Chen, L., Walther, D., Tsai, M.-H. M., Shi, L., Stove, C. P., & Baumann, M. H. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06451-2 · Cited by 52
Kozell, L. B., Eshleman, A. J., Wolfrum, K. M., Swanson, T. L., Bloom, S. H., Benware, S., Schmachtenberg, J. L., Schutzer, K. A., Schutzer, W. E., Janowsky, A., et al. (2024) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.002052 · Cited by 42
Taoussi, O., Berardinelli, D., Zaami, S., Tavoletta, F., Basile, G., Kronstrand, R., Auwärter, V., Busardò, F. P., & Carlier, J. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03735-0 · Cited by 40
Metadata
- Authors
- Papsun, D. M., Krotulski, A. J., & Logan, B. K.
- Affiliations
- NMS Labs, Toxicology Department, Horsham
- Fredric Rieders Family Foundation (US)
- Corresponding author
- Papsun, Donna M.
- Logan, Barry K.
- Venue
- American Journal of Forensic Medicine & Pathology
- Published
- 2022-08-31
- Volume
- 43
- Issue
- 4
- Pages
- 315-327
- ISSN
- 0195-7910 (ISSN-L)
- 1533-404X
- OpenAlex
- W4295756825
- Cited by
- 51
- References
- 106
- Citations by year
- 2026: 13 · 2025: 15 · 2024: 7 · 2023: 16
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Forensic Medicine & Pathology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Keywords
- novel synthetic opioids, isotonitazene, benzimidazolone, postmortem toxicology
- MeSH terms
- Analgesics, Opioid, Fentanyl, Humans, Imidazoles, Piperidines, United States, Cell Proliferation, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proliferation of Novel Synthetic Opioids in Postmortem Investigations After Core-Structure Scheduling for Fentanyl-Related Substances. https://app.cochat.ai/papers/10.1097/paf.0000000000000787
- The paper
- Papsun, D. M., Krotulski, A. J., & Logan, B. K. (2022). Proliferation of Novel Synthetic Opioids in Postmortem Investigations After Core-Structure Scheduling for Fentanyl-Related Substances. American Journal of Forensic Medicine & Pathology. https://doi.org/10.1097/paf.0000000000000787
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.